Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medigus Ltd Ads (MDGS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.16 +5.09%
on 07/08/19
3.48 -34.77%
on 07/12/19
-0.14 (-5.81%)
since 06/17/19
3-Month
2.11 +7.58%
on 06/03/19
3.48 -34.77%
on 07/12/19
-0.68 (-23.05%)
since 04/17/19
52-Week
2.11 +7.58%
on 06/03/19
4.39 -48.29%
on 07/18/18
-2.14 (-48.53%)
since 07/17/18

Most Recent Stories

More News
Thinking about buying stock in Aurora Cannabis, Infosys, Medigus, Stitch Fix, or Sg Blocks?

NEW YORK , July 12, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, INFY, MDGS, SFIX, and SGBX.

ACB : 7.41 (+3.49%)
SFIX : 28.64 (-1.31%)
MDGS : 2.27 (-3.40%)
INFY : 11.49 (-0.35%)
SGBX : 0.82 (unch)
Medigus Receives First Substantial Commercial Order for its Integrated Visualization Device

The company completed additional milestone in the agreement with A.M. Surgical, Inc. The agreed payment for the milestone is $650,000

MDGS : 2.27 (-3.40%)
Medigus to Invest $5 Million in Algomizer Group

The Investment is Part of the Company's Strategy to Enhance the Company and Create Shareholders' Value, the Company will Hold 17.9% at Algomizer Group

MDGS : 2.27 (-3.40%)
Medigus Reports $1.1 Million Order Backlog for Its Micro-Camera Business

Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a pioneer developer of minimally invasive endo-surgical tools and an innovator in direct visualization technology, today announces an order backlog of $1.1 Million...

MDGS : 2.27 (-3.40%)
Medigus Received European Patent Notice Allowance for ScoutCam Irrigation System Technology

Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endo-surgical tools and an innovator in direct visualization technology, announced today that it has received...

MDGS : 2.27 (-3.40%)
Medigus Completes patient enrollment of its First Multi-Center MUSE(TM) Clinical Study in China as Part of the CFDA Clearance Process

Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a pioneer developer of minimally invasive endo-surgical tools and an innovator in direct visualization technology, today announced that patient enrollment of...

MDGS : 2.27 (-3.40%)
Medigus Announces the Appointment of Liron Carmel as Chief Executive Officer

Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS) announced the appointment of Liron Carmel as the Company's new Chief Executive Officer effective April 1, 2019.

MDGS : 2.27 (-3.40%)
CAPD : 0.7500 (-25.00%)
Medigus Files Annual Report on Form 20-F for the Year Ended December 31, 2018

Medigus Ltd. ("Medigus" or the "Company") (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endo-surgical tools and an innovator in direct visualization technology, announced...

MDGS : 2.27 (-3.40%)
Medigus in Negotiations after Execution of Letter of Intent to Invest $5 Million in Algomizer Group

The Investment is Part of the Company's Strategy to Enhance the Company and Create Shareholders' Value

MDGS : 2.27 (-3.40%)
CBD Market Segments That Experts are Projecting to Rise

While many have heard or read the bombshell report by the Brightfield Report, that stated: "CBD is growing faster than cannabis in the U.S. and will soon be a $22 billion industry (by 2022). It's been...

TGIF.CN : 0.430 (+4.88%)
APHA : 6.56 (+4.13%)
TGIFF : 0.3188 (+0.50%)
MDGS : 2.27 (-3.40%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 8.910 (+1.48%)
BOSQF : 0.2744 (-6.22%)
APHA.TO : 8.59 (+4.00%)
BOSS.CN : 0.370 (-1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar